Rosuvastatin-induced Generalized Drug Eruption

Choi, Min Wha (Department of Dermatology, Nowon Eulji Medical Center, Eulji University) ;
Lee, June Hyunkyung (Department of Dermatology, Nowon Eulji Medical Center, Eulji University) ;
Noh, Tai Kyung (Department of Dermatology, Nowon Eulji Medical Center, Eulji University) ;
Han, Tae Young (Department of Dermatology, Nowon Eulji Medical Center, Eulji University)

Rosenson RS. Rosuvastatin: a new inhibitor of HMG-coA reductase for the treatment of dyslipidemia. Expert Rev Cardiovasc Ther 2003;1:495-505 https://doi.org/10.1586/14779072.1.4.495
Sommer M, Trautmann A, Stoevesandt J. Relief of photoallergy: atorvastatin replacing simvastatin. J Investig Allergol Clin Immunol 2015;25:138-140
Oda T, Sawada Y, Yamaguchi T, Ohmori S, Haruyama S, Yoshioka M, et al. Drug Eruption Caused by Rosuvastatin. J Investig Allergol Clin Immunol 2017;27:140-141 https://doi.org/10.18176/jiaci.0136
Nardi G, Lhiaubet-Vallet V, Leandro-Garcia P, Miranda MA. Potential phototoxicity of rosuvastatin mediated by its dihydrophenanthrene-like photoproduct. Chem Res Toxicol 2011;24:1779-1785 https://doi.org/10.1021/tx200341f
Marguery M-C, Chouini-Lalanne N, Drugeon C, Gadroy A, Bayle P, Journe F, et al. UV-B phototoxic effects induced by atorvastatin. Arch Dermatol 2006;142:1065-1086